OKLAHOMA CITY (KFOR) – Carter Healthcare, an Oklahoma company that provides home healthcare through subsidiaries in multiple states, as well as the former CEO and COO agreed to pay $22,948,004 to resolve allegations of Medicare and TRICARE fraud.

United States Attorney Robert J. Troester said the settlement resolves allegations that between 2013 and 2020, Carter Healthcare paid its home health medical directors in Oklahoma and Texas in order to induce referrals of Medicare and TRICARE home health patients.

“Offering illegal financial incentives to physicians in return for patient referrals undermines the integrity of our health care system,” said Troester. “Patients deserve care based on good medicine and informed choice that is free from the corrupting influence of money and other motivating enticements. We are committed to pursuing entities and individuals that offer kickbacks and the doctors that solicit or accept them.”

The Anti-Kickback Statute prohibits offering, paying, soliciting, or receiving remuneration to induce referrals of items or services covered by Medicare, Medicaid, and other federally funded programs.

The Physician Self-Referral Law, commonly known as the Stark Law, prohibits a hospital from billing Medicare for certain services referred by physicians with whom the hospital has an improper financial arrangement, including the payment of compensation that exceeds the fair market value of the services actually provided by the physician.

Both the Anti-Kickback Statute and the Stark Law are intended to ensure that physicians’ medical judgments are not compromised by improper financial incentives and instead are based on the best interests of their patients.

Claims submitted under the Anti-Kickback Statute and the Stark Law violate the False Claims Act.

“The taxpayer dollars that fund Medicare and Medicaid are meant to support the delivery of health care services most suitable for beneficiaries. The payment of kickbacks to medical providers to induce referrals for home health services can improperly divert those dollars and undermine the quality of care being provided to patients,” said Acting Special Agent in Charge Mike Stapleton with the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG). “This outcome is the result of cooperation amongst law enforcement partners focused on upholding the integrity of federal health care programs.”

Along with the civil settlement, Carter Healthcare entered into a five-year Corporate Integrity Agreement (CIA) with the U.S. Department of Health and Human Services-Office of Inspector General (HHS-OIG).

Stanley Carter and Brad Carter, Carter Healthcare’s previous CEO and COO respectively, also agreed to be excluded from participating in Medicare, Medicaid, and all other federal healthcare programs for a period of five years.

“Government-sponsored programs like Medicare and TRICARE are intended to support the healthcare needs of deserving Americans,” said FBI Oklahoma City Special Agent in Charge Edward J. Gray. “Today’s announcement demonstrates the FBI’s commitment to holding individuals and companies accountable for illegally profiting off of federally funded programs. We are determined to safeguard the integrity of our nation’s healthcare systems.”

The allegations resolved by the settlement were brought in a lawsuit filed under the qui tam, or whistleblower, provisions of the False Claims Act, which permit private parties to sue on behalf of the United States for false claims and to receive a share of any recovery.

In reaching this settlement, Defendants did not admit liability, and the government did not make any concessions about the legitimacy of the claims.

Separately, on the same date, the Defendants also settled another False Claims Act civil suit filed in the United States District Court of the Southern District of Florida for $7,175,000 to resolve allegations that, from 2014 through 2016, Defendants submitted claims for therapy services without regard to medical necessity and overbilled therapy services by upcoding patients’ diagnoses.

The total amount of the two settlement agreements, with interest, exceeds $30 million.